Annual report pursuant to Section 13 and 15(d)

Commitments and Contingencies (Details Textual)

v3.5.0.2
Commitments and Contingencies (Details Textual) - USD ($)
1 Months Ended 12 Months Ended
Jan. 14, 2014
Dec. 31, 2015
Jun. 30, 2016
Jun. 30, 2015
Sep. 01, 2014
Apr. 30, 2014
Dec. 30, 2013
Nov. 30, 2013
Apr. 30, 2013
Commitments and Contingencies [Line Items]                  
Research and Development Expense, Total     $ 3,156,000 $ 3,495,000          
Royalty Guarantees, Commitments, Amount     $ 200,000            
Long Term Purchase Commitment Expire Date     Dec. 31, 2015            
Settlement Liabilities, Current     $ 1,875,000            
Commitments [Member]                  
Commitments and Contingencies [Line Items]                  
Research Services Agreements Value Fulfilling Commitment   $ 3,000,000              
Research and Development Expense, Total       2,700,000          
License Costs $ 30,627                
Initial license fee 20,000                
Contractual Obligation, Due in Next Twelve Months             $ 78,000    
Contractual Obligation, Due in Second Year         $ 161,754        
Settlement Agreement [Member]                  
Commitments and Contingencies [Line Items]                  
Prepaid Expense           $ 1,000,000   $ 1,000,000 $ 1,000,000
Amended Agreement [Member]                  
Commitments and Contingencies [Line Items]                  
Research and Development Expense, Total       $ 2,100,000          
Second Eastern Affilate [Member] | iBio CMO LLC [Member]                  
Commitments and Contingencies [Line Items]                  
Lease Term     34 years            
Minimum [Member] | Commitments [Member]                  
Commitments and Contingencies [Line Items]                  
License Costs 25,000                
Maximum [Member] | Commitments [Member]                  
Commitments and Contingencies [Line Items]                  
License Costs $ 150,000                
Fraunhofer [Member]                  
Commitments and Contingencies [Line Items]                  
Royalty Guarantees, Commitments, Amount   $ 3,000,000 $ 4,000,000            
Other Commitments, Description     under the terms of the TTA and for a period of 15 years, the Company shall pay Fraunhofer one percent (1%) of all receipts derived by the Company from sales of products produced utilizing the iBioLaunch or iBioModulator technology and ten percent (10%) of all receipts derived by the Company from licensing either of those technologies to third parties.